Patents Assigned to Farco-Pharma GmbH

Bladder instillation composition with increased storage stability and containing chondroitin sulfate (4.5 mg/ml), hyaluronic acid (16 mg/ml) and phosphate buffer (PH 6.1 to 7.9), for the treatment of cystitis

Patent number: 11351113

Abstract: The invention relates to a combination drug with increased storage stability containing chondroitin sulfate (4.5 mg/ml), hyaluronic acid (16 mg/ml), a phosphate buffer (pH 6.1 to 7.9) and an electrolyte (e.g., an alkali salt, e.g., sodium chloride) for the treatment inflammations of the urogenital tract, in particular of the bladder, in particular for the treating cystitis, and to an instillation kit containing said drug.

Type: Grant

Filed: May 2, 2018

Date of Patent: June 7, 2022

Assignee: FARCO-PHARMA GMBH

Inventor: Andreas Meier
Bladder instillation composition containing chondroitin sulfate (20 mg/ml), hyaluronic acid (16 mg/ml) and a phosphate buffer (pH 6.1 to 7.9) with increased storage stability for treating cystitis

Patent number: 11141424

Abstract: The invention relates to a composition, in particular a pharmaceutical composition, which is suitable in particular for the prophylactic and/or therapeutic treatment preferably of inflammatory diseases of the urogenital tract, in particular inflammatory diseases of the bladder, preferably cystitis, to the uses thereof, to a storage or application device relating to same, to a packaging unit, and finally to a kit which is designed in particular as an instillation system.

Type: Grant

Filed: May 2, 2018

Date of Patent: October 12, 2021

Assignee: FARCO-PHARMA GMBH

Inventor: Andreas Meier
BLADDER INSTILLATION COMPOSITION WITH INCREASED STORAGE STABILITY AND CONTAINING CHONDROITIN SULFATE (4.5 MG/ML), HYALURONIC ACID (16 MG/ML) AND PHOSPHATE BUFFER (PH 6.1 TO 7.9), FOR THE TREATMENT OF CYSTITIS

Publication number: 20210145733

Abstract: The invention relates to a combination drug with increased storage stability containing chondroitin sulfate (4.5 mg/ml), hyaluronic acid (16 mg/ml), a phosphate buffer (pH 6.1 to 7.9) and an electrolyte (e.g., an alkali salt, e.g., sodium chloride) for the treatment inflammations of the urogenital tract, in particular of the bladder, in particular for the treating cystitis, and to an instillation kit containing said drug.

Type: Application

Filed: May 2, 2018

Publication date: May 20, 2021

Applicant: Farco-Pharma GmbH

Inventor: Andreas MEIER
BLADDER INSTILLATION COMPOSITION CONTAINING CHONDROITIN SULFATE (20 MG/ML), HYALURONIC ACID (16 MG/ML) AND A PHOSPHATE BUFFER (PH 6.1 TO 7.9) WITH INCREASED STORAGE STABILITY FOR TREATING CYSTITIS

Publication number: 20210137968

Abstract: The invention relates to a composition, in particular a pharmaceutical composition, which is suitable in particular for the prophylactic and/or therapeutic treatment preferably of inflammatory diseases of the urogenital tract, in particular inflammatory diseases of the bladder, preferably cystitis, to the uses thereof, to a storage or application device relating to same, to a packaging unit, and finally to a kit which is designed in particular as an instillation system.

Type: Application

Filed: May 2, 2018

Publication date: May 13, 2021

Applicant: Farco-Pharma GmbH

Inventor: Andreas MEIER
Process for collecting fragments which are obtained on shattering stones in body cavities of living humans and other mammals

Patent number: 4696297

Abstract: For collecting fragments obtained on crushing stones in body cavities of living humans or animals, a gelatin solution is introduced into the body cavity. The gelatin solution which is fluid at body temperature, is hardened during shattering of the stones by rinsing with a cooling fluid.

Type: Grant

Filed: April 23, 1985

Date of Patent: September 29, 1987

Assignee: Farco-Pharma GmbH

Inventors: Peter Pleines, Erich Wolf

Bladder instillation composition with increased storage stability and containing chondroitin sulfate (4.5 mg/ml), hyaluronic acid (16 mg/ml) and phosphate buffer (PH 6.1 to 7.9), for the treatment of cystitis

Bladder instillation composition containing chondroitin sulfate (20 mg/ml), hyaluronic acid (16 mg/ml) and a phosphate buffer (pH 6.1 to 7.9) with increased storage stability for treating cystitis

BLADDER INSTILLATION COMPOSITION WITH INCREASED STORAGE STABILITY AND CONTAINING CHONDROITIN SULFATE (4.5 MG/ML), HYALURONIC ACID (16 MG/ML) AND PHOSPHATE BUFFER (PH 6.1 TO 7.9), FOR THE TREATMENT OF CYSTITIS

BLADDER INSTILLATION COMPOSITION CONTAINING CHONDROITIN SULFATE (20 MG/ML), HYALURONIC ACID (16 MG/ML) AND A PHOSPHATE BUFFER (PH 6.1 TO 7.9) WITH INCREASED STORAGE STABILITY FOR TREATING CYSTITIS

Process for collecting fragments which are obtained on shattering stones in body cavities of living humans and other mammals